EMA Updates Clinical Requirements in Adult, Pediatric Heart Failure Trials

Wednesday, June 17, 2015


The European Medicines Agency released final guidance on the primary and secondary endpoints sponsors should use to evaluate drugs to treat acute heart failure — along with recommendations on designing and conducting such studies in children.

View All News »